Astrazeneca (AZN) EPS (Diluted) (2009 - 2026)
Astrazeneca (AZN) recorded EPS (Diluted) of $2.00 in Q3 2026, up 23.1% from $1.62 a year earlier and up 24.3% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EPS (Diluted) (2009 - 2026) Analysis & Trends
On a TTM basis, Astrazeneca's EPS (Diluted) came in at $7.06 as of Sep 30, 2026, up 17.5% year-over-year; for FY2025, it came in at $6.55, up 45.4% from FY2024.
- Annual EPS (Diluted) has increased for three straight years, with a five-year compound annual growth rate of 21.9% (FY2020 to FY2025).
- Across earlier years, EPS (Diluted) came in at $4.50 in FY2024 (+18.1%), $3.81 in FY2023 (+80.9%), $2.11 in FY2022 and $0.08 in FY2021 (-96.8%).
- The Q3 2026 figure is the highest quarterly EPS (Diluted) since Q4 2014.
- On a year-over-year basis, EPS (Diluted) has increased for 12 consecutive quarters, with growth averaging 35.1% over the last eight quarters.
- Peak year-over-year performance for EPS (Diluted) in the last five years was growth of 362.5% in Q2 2023, against a decline of 77.3% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.61 (Q2 2026), $1.97 (Q1 2026) and $1.49 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 7.22 |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 2.38 |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 2.04 |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 2.00 |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 7.08 |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.94 |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 0.56 |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 2.56 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.00 |
| Jun 30, 2026 | 1.61 |
| Mar 31, 2026 | 1.97 |
| Dec 31, 2025 | 1.49 |
| Sep 30, 2025 | 1.62 |
| Jun 30, 2025 | 1.57 |
| Mar 31, 2025 | 1.87 |
| Dec 31, 2024 | 0.96 |
| Sep 30, 2024 | 0.91 |
| Jun 30, 2024 | 1.23 |
| Mar 31, 2024 | 1.40 |
| Dec 31, 2023 | 0.61 |
| Sep 30, 2023 | 0.88 |
| Jun 30, 2023 | 1.17 |
| Mar 31, 2023 | 1.16 |
| Dec 31, 2022 | 0.58 |
| Sep 30, 2022 | 1.15 |
| Jun 30, 2022 | 0.25 |
| Mar 31, 2022 | 0.27 |
| Dec 31, 2021 | -0.24 |
API Access
Astrazeneca EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();